ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP5095	Overview of proinflammatory and profibrotic mediators	40/635	73/6030	5.57767969915994e-21	2.69401929469425e-18	2.18997318714385e-18	6356/6357/6361/6362/6347/6364/6370/10344/6348/6351/9560/1437/1440/2919/3627/6373/284340/2920/2921/6374/6372/4283/3458/3586/3589/3605/29949/3552/3553/3557/51561/11009/3569/4312/4314/4318/5008/5196/6696/7124	40
WP5055	Burn wound healing	37/635	97/6030	4.66592131609082e-13	1.0707757614103e-10	8.70435565012621e-11	8038/6347/57124/1277/1278/2919/3579/2162/2200/3082/3383/3552/3553/3569/3624/3853/23643/440823/4312/4322/4313/4314/4318/64332/64127/5159/6282/6280/6423/6678/7042/7043/7076/7097/51311/3371/7124	37
WP5115	Network map of SARS-CoV-2 signaling pathway	55/635	190/6030	6.65078112677204e-13	1.0707757614103e-10	8.70435565012621e-11	59272/183/335/341/8542/684/715/838/6356/6347/6364/10344/6348/6351/1234/1051/629/3426/5199/1294/2919/3627/2920/2921/6374/6372/4283/3577/3579/84985/3091/10964/8519/10410/3458/3586/3605/8807/3552/3553/3569/3699/3726/116844/64386/114548/4939/5196/5743/6288/6289/6403/5054/6772/7124	55
WP2806	Complement system	29/635	75/6030	1.12927776974463e-10	1.36360290696665e-08	1.1084752845125e-08	133/335/715/717/720/722/728/27202/958/1604/22918/629/3426/5199/2162/2214/2219/2357/2769/3383/3687/3689/5648/5329/6401/6402/6403/6696/7097	29
WP4891	COVID-19 adverse outcome pathway	11/635	13/6030	1.0436291067837e-09	1.00814571715306e-07	8.19523488063833e-08	59272/183/6347/6348/1440/3627/3586/3553/3559/3569/7124	11
WP3624	Lung fibrosis	22/635	52/6030	2.79570915733766e-09	2.25054587165682e-07	1.8294728345385e-07	6356/6347/6348/6351/1232/1051/1215/1437/1440/2920/57105/2252/26585/3082/3553/3569/4313/4318/5328/6696/7076/7124	22
WP691	Tamoxifen metabolism	12/635	17/6030	6.34588077286673e-09	4.37865773327804e-07	3.55941883951773e-07	1545/1557/1558/1559/1565/1576/2326/2328/6783/6822/54657/7364	12
WP619	Type II interferon signaling	17/635	34/6030	8.18728127024128e-09	4.94307106690817e-07	4.01823146552631e-07	4261/3627/4283/2633/3383/3433/3458/3553/3659/9636/4843/5698/8651/9021/6688/6772/6890	17
WP2882	Nuclear receptors meta-pathway	59/635	268/6030	1.53743141229612e-08	8.25088191265583e-07	6.70715692147896e-07	5243/1244/64240/64241/51129/335/345/8553/330/874/6347/6364/1545/1555/1557/1559/1576/1551/1907/9982/2938/2939/1839/3082/3458/3589/3553/3726/23764/4199/8431/9971/9970/5142/5743/6286/6319/5272/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/8140/5552/27286/2040/6822/7042/7056/7124/54657/7364	59
WP5088	Prostaglandin signaling	15/635	28/6030	1.87356079567133e-08	9.04929864309252e-07	7.35619133458322e-07	834/6347/6348/2919/3627/4283/3458/3605/3552/3553/3569/4318/114548/9536/7124	15
WP5039	SARS-CoV-2 innate immunity evasion and cell-specific immune response	23/635	63/6030	3.54735753280603e-08	1.55761244395028e-06	1.26618599017861e-06	59272/6347/6348/6351/1437/2919/3627/6373/284340/2920/2921/6374/6372/4283/3579/3433/8519/3586/3569/3902/5196/6772/7124	23
WP2865	IL1 and megakaryocytes in obesity	13/635	23/6030	7.32638227201552e-08	2.94886886448625e-06	2.39714086619455e-06	6347/1232/2205/1839/3383/3458/3553/4318/114548/7941/6280/7076/7097	13
WP455	GPCRs, class A rhodopsin-like	33/635	118/6030	7.97421859368232e-08	2.96272890826812e-06	2.40840772100689e-06	51554/134/27202/1230/2826/1232/1234/1237/10803/3577/3579/57105/1909/2151/2867/2357/2358/29909/2828/8111/8843/3274/3352/4543/64106/4888/53829/5031/5724/5737/5739/6752/56670	33
WP5198	Inflammatory bowel disease signaling	16/635	35/6030	1.13471344238472e-07	3.91476137622728e-06	3.18231664668797e-06	50943/3458/3586/3594/3595/8807/3552/50615/51561/3569/4094/64127/6772/30009/7097/7124	16
WP129	Matrix metalloproteinases	13/635	24/6030	1.44569543733985e-07	4.65513930823432e-06	3.78417121493168e-06	4312/4319/4321/4322/4327/4313/10893/64386/4314/4316/4318/7076/7124	13
WP1533	Vitamin B12 metabolism	16/635	37/6030	2.93839498304012e-07	8.87027985505236e-06	7.21066663601292e-06	335/338/875/6347/8029/3383/3458/3553/3569/3949/6288/6289/5054/6648/6947/7124	16
WP3617	Photodynamic therapy-induced NF-kB survival signaling	15/635	33/6030	3.12984460184815e-07	8.89244083936857e-06	7.2286813404914e-06	597/330/1437/2920/3383/3552/3553/3569/4312/4313/4314/4318/5743/6401/7124	15
WP2328	Allograft rejection	24/635	76/6030	4.22284287170767e-07	1.10191626553402e-05	8.95749737483252e-06	5243/717/720/721/958/1604/941/1493/6373/4283/50943/10578/3002/3134/3458/3586/3605/3552/3553/3559/120892/5551/6772/7124	24
WP4754	IL-18 signaling pathway	51/635	239/6030	4.33466025779429e-07	1.10191626553402e-05	8.95749737483252e-06	321/467/330/6362/6347/6364/6348/6351/1051/9076/24146/6900/1277/1278/1281/2920/2921/338442/3383/3458/3586/8807/3553/3559/3569/3659/3801/4312/4322/4313/4314/4318/4688/64332/4843/8431/7941/5743/6004/8698/9021/6696/30009/7052/7076/7124/7127/4982/79931/7185/80149	51
WP530	Cytokines and inflammatory response	11/635	19/6030	5.56432726472805e-07	1.34378503443182e-05	1.09236529986503e-05	1437/1440/2919/2920/3458/3586/3589/3552/3553/3569/7124	11
WP4462	Platelet-mediated interactions with vascular and circulating cells	10/635	17/6030	1.53132630531005e-06	3.44461199865261e-05	2.80013136209529e-05	6347/958/3383/3553/5196/6401/6403/7042/7043/7097	10
WP24	Peptide GPCRs	16/635	41/6030	1.56897440932417e-06	3.44461199865261e-05	2.80013136209529e-05	728/1230/2826/1232/1234/1237/10803/3577/3579/10663/1909/2357/2358/4888/6752/7253	16
WP2877	Vitamin D receptor pathway	34/635	143/6030	3.21276720201439e-06	6.74681112423023e-05	5.4844950405097e-05	5243/248/768/838/875/958/634/1493/1594/1555/1559/1565/1576/168002/1673/50486/3091/3488/3726/5653/639/6273/6279/6280/10568/6696/6699/79689/412/6822/7042/7056/4982/54210	34
WP15	Selenium micronutrient network	19/635	59/6030	4.92497321307191e-06	9.91150859130722e-05	8.057083370508e-05	335/338/875/6347/1734/3383/3458/3553/3569/8564/8942/3949/5743/6288/6289/5054/6648/7124/7498	19
WP702	Metapathway biotransformation Phase I and II	30/635	125/6030	1.00005722836213e-05	0.000193211056519563	0.00015706161944382	50515/9435/9469/1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420/2326/2327/2328/92292/2938/2939/9027/4837/6783/6822/54657/79799/7364	30
WP4494	Selective expression of chemokine receptors during T-cell polarization	11/635	24/6030	1.11910933393836e-05	0.000207896080112395	0.000168999101845752	6348/6351/1230/1232/1234/1437/3458/3594/3595/7042/7043	11
WP43	Oxidation by cytochrome P450	14/635	38/6030	1.55762291804553e-05	0.000278641433117034	0.000226508128043268	1545/56603/1594/1555/1562/1557/1558/1559/1565/1576/1551/8529/260293/9420	14
WP5218	Extrafollicular B cell activation by SARS-CoV-2	19/635	65/6030	2.36073021896909e-05	0.000407225962772169	0.000331034726193786	720/958/941/83416/29851/3433/8519/3458/3586/3569/9636/3687/3689/4094/639/6402/57823/30009/7124	19
WP2876	Pregnane X receptor pathway	11/635	29/6030	9.46401883315239e-05	0.00157624865393538	0.00128133539918905	5243/1244/1555/1557/1559/1576/1551/2939/27286/6822/54657	11
WP430	Statin inhibition of cholesterol production	10/635	25/6030	0.000117253528050133	0.00182688561445853	0.00148507864049914	64240/64241/335/337/338/341/345/3949/4547/6713	10
WP5092	Interactions of natural killer cells in pancreatic cancer	10/635	25/6030	0.000117253528050133	0.00182688561445853	0.00148507864049914	6347/6348/6351/1437/2214/3002/3458/4277/5551/7124	10
WP2289	Drug induction of bile acid pathway	7/635	13/6030	0.000135051272951633	0.00203843015111371	0.00165704357930787	5243/1244/1576/9971/9970/200931/6822	7
WP2431	Spinal cord injury	23/635	98/6030	0.00015517180283976	0.00227115093247286	0.00184622272597227	301/63827/6347/50515/1282/2919/3627/2920/2212/3383/3458/3552/3553/3569/10288/11025/4321/4318/4843/5320/5743/6403/7124	23
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	18/635	68/6030	0.000160373147472439	0.00227824206556436	0.00185198712096656	6347/958/1594/1673/10964/3458/3569/9636/5600/6300/64127/4939/91543/6258/6772/7097/51311/7124	18
WP5090	Complement system in neuronal development and plasticity	22/635	93/6030	0.000190007302751825	0.00258827355591806	0.0021040122836601	715/717/720/721/722/725/728/27202/843/1604/629/3426/5199/10584/2219/8547/3458/3687/3689/5648/7042/7043	22
WP1604	Codeine and morphine metabolism	6/635	10/6030	0.000192914799198862	0.00258827355591806	0.0021040122836601	5243/1244/1558/1565/1576/7364	6
WP2911	miRNA targets in ECM and membrane receptors	9/635	22/6030	0.000211528339712483	0.00276130238057107	0.00224466773009264	1278/1281/1282/1284/1290/50509/1291/1293/7058	9
WP545	Complement activation	8/635	18/6030	0.000242154795015547	0.00300484396829582	0.00244264312994299	715/717/720/721/1604/629/5199/5648	8
WP2875	Constitutive androstane receptor pathway	10/635	27/6030	0.000248848361763629	0.00300484396829582	0.00244264312994299	5243/1244/1555/1557/1559/1576/2939/9970/6822/54657	10
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	10/635	27/6030	0.000248848361763629	0.00300484396829582	0.00244264312994299	59272/6347/2939/3553/3569/4312/4314/5593/23657/7124	10
WP117	GPCRs, other	12/635	37/6030	0.000259187552527498	0.00305335580172637	0.00248207848761891	27202/1234/3577/3579/1909/29933/11245/53831/59340/53829/5737/6752	12
WP2880	Glucocorticoid receptor pathway	17/635	65/6030	0.000283965224260711	0.00320916075503503	0.0026087326176922	51129/8553/330/6347/6364/1907/9982/3589/8972/9970/5142/5743/6286/5272/5552/2040/7056	17
WP176	Folate metabolism	14/635	48/6030	0.000285701682125272	0.00320916075503503	0.0026087326176922	335/338/875/6347/3383/3458/3553/3569/3949/6288/6289/5054/6648/7124	14
WP4559	Interactions between immune cells and microRNAs in tumor microenvironment	10/635	28/6030	0.000351079237541166	0.00385389253937234	0.0031328362584415	6347/29126/941/1493/3627/3559/8651/7042/7043/51311	10
WP5174	Ulcerative colitis signaling	7/635	15/6030	0.000419083242828069	0.00449816013968794	0.00365656256315485	50943/3458/3586/4094/64127/7097/7124	7
WP4329	miRNAs involvement in the immune response in sepsis	12/635	39/6030	0.000449033344841359	0.00461453416081652	0.00375116321670385	6348/6351/3002/3383/3586/3552/3569/3659/3934/407008/51311/7124	12
WP5097	CCL18 signaling pathway	12/635	39/6030	0.000449033344841359	0.00461453416081652	0.00375116321670385	467/1237/1278/1437/3091/440823/4313/4318/6615/6772/7291/652995	12
WP2848	Pluripotent stem cell differentiation pathway	11/635	34/6030	0.000478493584905958	0.00479417860227867	0.00389719651007942	3577/22943/2255/3082/3589/3569/3624/6469/7043/7472/7474	11
WP5094	Orexin receptor pathway	24/635	112/6030	0.000486365945158705	0.00479417860227867	0.00389719651007942	8553/2920/1734/1846/1959/1960/1839/3091/3383/3586/3553/3569/3726/3949/23764/4322/4314/64106/8013/5069/6401/6696/3371/7124	24
WP299	Nuclear receptors in lipid metabolism and toxicity	9/635	26/6030	0.000902407411063466	0.00854632901065988	0.00694732640509128	5243/1244/64240/1594/1555/1559/1576/9971/9970	9
WP453	Inflammatory response pathway	9/635	26/6030	0.000902407411063466	0.00854632901065988	0.00694732640509128	958/941/1277/1278/1281/3458/3559/3568/3918	9
WP75	Toll-like receptor signaling pathway	19/635	84/6030	0.000925451157628045	0.0085960174833528	0.00698771825496479	6348/6351/958/941/3627/6373/4283/3553/3569/23643/1326/5600/6300/8503/6696/6772/7097/51311/7124	19
WP558	Complement and coagulation cascades	13/635	48/6030	0.00101967417058512	0.00929250234703041	0.00755389206808836	715/717/721/728/1604/629/3426/5648/5328/5329/5054/7056/7450	13
WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	11/635	37/6030	0.00106557806285311	0.00953100378440841	0.00774777032054993	84674/834/838/50506/3553/4210/91662/114548/199713/64127/639	11
WP4724	Omega-9 fatty acid synthesis	6/635	13/6030	0.00119337006271674	0.0104799589144034	0.00851917767259991	2180/2182/54898/3992/9415/6319	6
WP465	Tryptophan metabolism	10/635	33/6030	0.00152193867636558	0.0131267210836531	0.0106707354564729	8854/316/1545/1562/1576/9420/3620/8942/4129/6999	10
WP5033	Genes associated with the development of rheumatoid arthritis	7/635	18/6030	0.00156209165050039	0.0132366713542401	0.010760114231517	958/4261/1493/3559/23569/6583/7185	7
WP697	Estrogen metabolism	6/635	14/6030	0.00190413393664741	0.0158568395069086	0.0128900536909162	1545/1576/2938/412/6783/7364	6
WP716	Vitamin A and carotenoid metabolism	10/635	34/6030	0.00195670746447375	0.0160184695820478	0.013021443073126	64240/64241/8854/1381/1382/56603/9227/29881/5948/6258	10
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	6/635	15/6030	0.00289416773252698	0.0232980502468422	0.0189390274426765	335/338/3949/9388/4547/255738	6
WP4969	RAS and bradykinin pathways in COVID-19	8/635	25/6030	0.00306874999405733	0.024181581886862	0.0196572519206702	1636/59272/183/1576/3552/3553/5054/7124	8
WP167	Eicosanoid synthesis	7/635	20/6030	0.00315411937654722	0.024181581886862	0.0196572519206702	246/1800/5320/80339/5730/9536/5743	7
WP5044	Kynurenine pathway and links to cell senescence	7/635	20/6030	0.00315411937654722	0.024181581886862	0.0196572519206702	3620/169355/3458/8564/8942/6999/7124	7
WP3942	PPAR signaling pathway	13/635	54/6030	0.00323889379798974	0.0244435266317038	0.0198701872804305	2180/2182/51129/335/345/126129/2172/9415/4199/4312/4973/6258/6319	13
WP4478	LTF danger signal response pathway	6/635	16/6030	0.00422392384838916	0.0299679413559436	0.0243609940629115	3552/3553/3569/7097/7124/54210	6
WP4493	Cells and molecules involved in local acute inflammatory response 	6/635	16/6030	0.00422392384838916	0.0299679413559436	0.0243609940629115	3383/3552/3569/3689/6403/7124	6
WP516	Hypertrophy model	6/635	16/6030	0.00422392384838916	0.0299679413559436	0.0243609940629115	467/11072/1839/3458/3552/8013	6
WP2884	NRF2 pathway	22/635	116/6030	0.00423926428493985	0.0299679413559436	0.0243609940629115	1244/874/2938/2939/1839/3082/23764/4199/6514/6515/11182/115584/159963/6527/200010/11254/340024/6532/23657/7042/54657/7364	22
WP4538	Regulatory circuits of the STAT3 signaling pathway	16/635	75/6030	0.00428113447942051	0.0299679413559436	0.0243609940629115	1271/1439/1441/2151/3595/3601/50615/3559/3568/3575/5600/6300/9180/5159/11122/9021	16
WP4304	Oligodendrocyte specification and differentiation, leading to myelin components for CNS	7/635	22/6030	0.00575612687620315	0.0397172754458017	0.0322862454860718	2919/2920/3553/5354/6469/55553/7124	7
WP3967	miR-509-3p alteration of YAP1/ECM axis	6/635	17/6030	0.00595581892567375	0.0405163456493017	0.0329358111086184	1277/1281/1909/6678/7058/7291	6
WP4239	Epithelial to mesenchymal transition in colorectal cancer	24/635	134/6030	0.00615179619326146	0.041268299463129	0.0335470757322591	9076/24146/51208/1282/1284/94234/11211/3091/3678/5600/6300/4313/4318/4854/4855/8503/6615/6678/7042/7043/7291/7480/7472/7474	24
WP3893	Development and heterogeneity of the ILC family	7/635	23/6030	0.00753833731948524	0.0498769441823475	0.0405450586902378	3458/3605/3553/51561/3569/30009/7124	7
WP4723	Omega-3 / omega-6 fatty acid synthesis	5/635	13/6030	0.00798172915706728	0.0520969619305878	0.0423497151576969	2180/2182/54898/3992/9415	5
WP497	Urea cycle and metabolism of amino groups	6/635	18/6030	0.00815268256326044	0.0524608758444713	0.0426455414405313	384/445/1373/2628/4942/5009	6
WP3929	Chemokine signaling pathway	26/635	152/6030	0.00825471338339506	0.0524608758444713	0.0426455414405313	6356/6361/6364/6370/10344/6348/6351/1230/2826/1232/1237/10803/3627/6373/2921/6374/4283/3579/10663/2268/2786/3055/4067/5196/8503/6772	26
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	9/635	35/6030	0.00860261271541116	0.05396184339667	0.0438656806951246	285/597/664/3091/4843/5743/5054/6515/7043	9
WP4210	Tryptophan catabolism leading to NAD+ production	5/635	14/6030	0.0113581709461894	0.0694429945191075	0.056450336614639	3620/8564/8942/10135/6999	5
WP5063	FOXP3 in COVID-19	5/635	14/6030	0.0113581709461894	0.0694429945191075	0.056450336614639	941/50943/3559/3569/3575	5
WP4496	Signal transduction through IL1R	8/635	31/6030	0.0127008486759264	0.0766813738809053	0.062334428370007	3552/3553/3557/3569/11213/7042/7043/7124	8
WP2374	Oncostatin M signaling pathway	13/635	64/6030	0.0144022419350047	0.0858800352420649	0.0698120369299122	6347/1051/3091/3726/3949/4312/4322/4314/5008/9180/5054/9021/6772	13
WP4389	Bile acids synthesis and enterohepatic circulation 	4/635	10/6030	0.0152278659612155	0.0896958446252086	0.072913915321353	64240/64241/3949/6555	4
WP5109	Familial hyperlipidemia type 2	5/635	15/6030	0.0155901725530206	0.0907235342543245	0.0737493260910168	335/337/338/3949/255738	5
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	10/635	45/6030	0.0165023432856468	0.0948884738924691	0.0771350131020834	2180/2182/9023/54898/3992/9415/4597/6319/8435/6713	10
WP727	Monoamine transport	6/635	21/6030	0.0181365521899637	0.103058290679441	0.0837762720353743	183/3553/6532/6999/7124/4982	6
WP4747	Netrin-UNC5B signaling pathway	10/635	46/6030	0.0191650317758235	0.107636166833986	0.0874976358920706	249/6347/1003/1277/3383/3586/3552/54538/6401/7124	10
WP247	Small ligand GPCRs	5/635	16/6030	0.020756649236944	0.11523519059131	0.0936748961328507	4543/5724/5737/5739/8698	5
WP4136	Fibrin complement receptor 3 signaling pathway	8/635	35/6030	0.0260604343709549	0.142238040260725	0.115625561768008	6347/3627/2921/3569/3689/23643/4843/7124	8
WP5130	Th17 cell differentiation pathway	12/635	62/6030	0.026209493961086	0.142238040260725	0.115625561768008	50943/3091/3458/3605/3553/50615/51561/3559/3569/9021/6772/30009	12
WP3287	Overview of nanoparticle effects	5/635	17/6030	0.0269236618666399	0.142902512984473	0.116165712854328	1001/1282/3569/5743/7124	5
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	5/635	17/6030	0.0269236618666399	0.142902512984473	0.116165712854328	249/1594/5251/142680/6696	5
WP364	IL6 signaling pathway	9/635	42/6030	0.0279869679416226	0.144685958091615	0.117615478627378	183/3055/3569/3659/3726/639/9021/6772/7076	9
WP4197	Immune response to tuberculosis	6/635	23/6030	0.0281583438107905	0.144685958091615	0.117615478627378	3437/8519/3659/8651/6772/6890	6
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	6/635	23/6030	0.0281583438107905	0.144685958091615	0.117615478627378	1636/59272/183/3569/114548/7124	6
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	38/635	265/6030	0.0284614182664599	0.144703842344212	0.117630016768859	285/1277/1278/1281/1282/1284/1290/50509/84699/9586/1440/1441/2255/2252/2254/2786/3082/3091/3559/3575/3678/3687/3689/3918/10319/23566/4843/5008/9180/5159/5209/5228/6514/6515/6696/7058/3371/7450	38
WP3611	Photodynamic therapy-induced AP-1 survival signaling	10/635	49/6030	0.0290326219113927	0.146070378991694	0.118740876896376	602/2252/1839/3458/3569/3726/5600/6300/4313/7124	10
WP4495	IL-10 anti-inflammatory signaling pathway 	4/635	12/6030	0.0302716782252534	0.148995933624675	0.121119065581353	3586/3552/3569/6772	4
WP2873	Aryl hydrocarbon receptor pathway	8/635	36/6030	0.0305267080107481	0.148995933624675	0.121119065581353	1545/2939/3458/3553/3726/8140/7124/54657	8
WP236	Adipogenesis	19/635	115/6030	0.0305395391901508	0.148995933624675	0.121119065581353	183/1051/1271/56603/1959/3091/3569/10135/5008/80339/6258/6319/5054/8651/9021/6772/7124/7291/7480	19
WP474	Endochondral ossification	11/635	57/6030	0.0331549366343429	0.158552815786016	0.128887872481604	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP4808	Endochondral ossification with skeletal dysplasias	11/635	57/6030	0.0331549366343429	0.158552815786016	0.128887872481604	9507/249/50515/4256/4322/4318/5328/55553/6696/6772/7042	11
WP5149	Lipid metabolism in senescent cells	5/635	18/6030	0.0341432692910167	0.160899793775617	0.130795735160304	84647/50487/283748/7941/5743	5
WP5036	Angiotensin II receptor type 1 pathway	6/635	24/6030	0.0343119643041172	0.160899793775617	0.130795735160304	59272/183/1277/1278/3091/3589	6
WP4298	Acute viral myocarditis	14/635	79/6030	0.0346506802965709	0.160925755608113	0.130816839581184	834/1232/1234/1604/941/3458/3586/3569/3689/4318/64127/8651/6772/7124	14
WP5108	Familial  hyperlipidemia type 1	4/635	13/6030	0.0401783222555585	0.183076694805988	0.14882337836468	51129/335/337/3949	4
WP554	ACE inhibitor pathway	4/635	13/6030	0.0401783222555585	0.183076694805988	0.14882337836468	1636/59272/183/1215	4
WP5066	FOXA2 pathway	5/635	19/6030	0.0424529200946941	0.191633274819974	0.15577903782903	1244/338/2938/2939/4547	5
WP3937	Microglia pathogen phagocytosis pathway	8/635	39/6030	0.0469901225342455	0.210150270222598	0.170831537088436	2207/2209/3055/3689/4067/4688/8503/54210	8
WP2849	Hematopoietic stem cell differentiation	9/635	46/6030	0.0475041212528729	0.21049991344163	0.171115762697456	4261/1437/1440/3552/3553/3569/4778/6688/23650	9
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	6/635	26/6030	0.0490584263550092	0.215411090267904	0.175108067276732	8529/5730/9536/5737/5739/5743	6
WP12	Osteoclast signaling	4/635	14/6030	0.0517063827793061	0.221010467985884	0.179659811613239	1513/8111/6696/4982	4
WP2879	Farnesoid X receptor pathway	4/635	14/6030	0.0517063827793061	0.221010467985884	0.179659811613239	1576/8431/9971/6822	4
WP3971	OSX and miRNAs in tooth development	4/635	14/6030	0.0517063827793061	0.221010467985884	0.179659811613239	249/22943/4854/4855	4
WP5087	Malignant pleural mesothelioma	50/635	381/6030	0.0560336321480973	0.237405651995886	0.192987486530381	72/285/467/834/6347/6351/29126/1001/1003/1282/1284/1437/1440/115908/1496/2919/3627/6374/22943/2255/2252/2254/8061/11211/1839/3082/3091/3620/3586/3553/3569/3689/3918/10319/4313/4314/4318/114548/5159/5228/5328/6401/6423/6425/8140/6678/6772/7480/7472/7474	50
WP5122	Prostaglandin and leukotriene metabolism in senescence 	6/635	27/6030	0.0576900234031578	0.242298098293263	0.19696456502863	246/3488/5600/5730/9536/5743	6
WP98	Prostaglandin synthesis and regulation	8/635	41/6030	0.0606810269742847	0.252663241625685	0.2053904089057	301/1909/3290/5730/9536/5737/5739/5743	8
WP3	Transcriptional activation by NRF2 in response to phytochemicals	4/635	15/6030	0.0648395501343188	0.265402565380305	0.215746228368429	1051/2939/4094/23657	4
WP4842	Mammalian disorder of sexual development	4/635	15/6030	0.0648395501343188	0.265402565380305	0.215746228368429	84733/2254/5600/5730	4
WP5222	2q13 copy number variation syndrome	9/635	49/6030	0.0669659371694495	0.271802921452471	0.220949089466649	1437/3552/3553/3557/51561/3569/8651/9021/6772	9
WP4595	Urea cycle and associated pathways	5/635	22/6030	0.0740773479144095	0.298161325355498	0.242375883965568	445/1373/4843/4942/5009	5
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	11/635	65/6030	0.0751700050727843	0.300058780579792	0.243918328770322	22943/1959/94234/2619/3458/3488/5653/5650/4488/22822/7474	11
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	19/635	128/6030	0.0766584019827078	0.303491870144655	0.246709093525022	116/8553/720/721/1051/2328/3091/3586/3552/3553/3557/3569/3764/5354/6507/6532/6752/7124/11076	19
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	7/635	36/6030	0.0779096238075692	0.305937791049235	0.248697387079361	684/8519/10581/10410/3726/5600/6300	7
WP2815	Mammary gland development pathway - Involution (Stage 4 of 4)	3/635	10/6030	0.0794620926950119	0.307318798074827	0.249820010203575	1116/4318/9021	3
WP3413	NOTCH1 regulation of endothelial cell calcification	4/635	16/6030	0.0795338504334438	0.307318798074827	0.249820010203575	249/2702/4256/55553	4
WP3668	Hypothesized pathways in pathogenesis of cardiovascular disease	5/635	23/6030	0.0868326268320814	0.332858402856312	0.27058120140657	285/2022/2200/4053/5054	5
WP5144	NRP1-triggered signaling pathways in pancreatic cancer 	9/635	52/6030	0.0908053835234431	0.345346458597032	0.28073276464355	1003/1277/1278/3082/4313/4318/6615/7042/7043	9
WP5083	Neuroinflammation and glutamatergic signaling	17/635	115/6030	0.0931172470416646	0.351372111883781	0.285631029165632	2893/2898/2906/116443/3458/3586/3552/3553/3569/29968/6507/6515/9021/6772/7042/7043/7124	17
WP5111	Familial hyperlipidemia type 4	4/635	17/6030	0.0957216007616913	0.358399481921681	0.291343591057616	335/337/3949/4547	4
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	5/635	24/6030	0.100653853813125	0.369645407563715	0.300485424476987	246/8529/57105/1800/2358	5
WP4583	Biomarkers for urea cycle disorders	3/635	11/6030	0.101021105172692	0.369645407563715	0.300485424476987	445/2628/5009	3
WP4707	Aspirin and miRNAs	3/635	11/6030	0.101021105172692	0.369645407563715	0.300485424476987	283120/4597/5743	3
WP3927	BMP signaling in eyelid development	4/635	18/6030	0.113315409753313	0.409155790858809	0.332603486957254	2255/2296/3625/6469	4
WP4545	Oxysterols derived from cholesterol	6/635	32/6030	0.113513200776564	0.409155790858809	0.332603486957254	134526/9023/1576/9420/3605/3638	6
WP3892	Development of pulmonary dendritic cells and macrophage subsets	3/635	12/6030	0.124604247488506	0.43611486620977	0.35451856836928	55509/1437/6688	3
WP5110	Familial hyperlipidemia type 3	3/635	12/6030	0.124604247488506	0.43611486620977	0.35451856836928	335/337/3949	3
WP5112	Familial hyperlipidemia type 5	3/635	12/6030	0.124604247488506	0.43611486620977	0.35451856836928	335/337/3949	3
WP5188	Retinol metabolism	3/635	12/6030	0.124604247488506	0.43611486620977	0.35451856836928	316/1551/9227	3
WP3646	Hepatitis C and hepatocellular carcinoma	8/635	48/6030	0.126471718794357	0.438531350051669	0.356482932481797	330/1284/3577/3091/3569/4312/4843/5743	8
WP4756	Renin-angiotensin-aldosterone system (RAAS)	6/635	33/6030	0.12711053624686	0.438531350051669	0.356482932481797	1636/183/1215/84699/9586/3283	6
WP4767	FGFR3 signaling in chondrocyte proliferation and terminal differentiation	5/635	26/6030	0.131318916318635	0.446562458593566	0.36301143523025	2254/5600/6300/6615/6772	5
WP2895	Differentiation of white and brown adipocyte	4/635	19/6030	0.132212073662277	0.446562458593566	0.36301143523025	1051/253738/3224/27129	4
WP3599	Transcription factor regulation in adipogenesis	4/635	19/6030	0.132212073662277	0.446562458593566	0.36301143523025	1051/3569/7124/7291	4
WP4879	Overlap between signal transduction pathways contributing to LMNA laminopathies	8/635	49/6030	0.138082603013852	0.463152064275627	0.376497155878411	1051/1513/3726/4129/6696/7042/4982/7480	8
WP4655	Cytosolic DNA-sensing pathway	9/635	57/6030	0.140228926722957	0.467107390394402	0.379712447678135	834/843/6351/9560/3627/3553/3569/9636/81030	9
WP4008	NO/cGMP/PKG mediated neuroprotection	6/635	34/6030	0.141455127557696	0.467964565824431	0.380409247145065	2906/3458/3553/4843/5593/7124	6
WP4787	Osteoblast differentiation and related diseases	14/635	98/6030	0.146041143254039	0.479583894723193	0.389854620751337	2255/2252/2254/11211/5600/6300/4854/4855/5288/8503/6772/7480/7472/7474	14
WP4917	Proximal tubule transport	7/635	42/6030	0.147177576109329	0.479583894723193	0.389854620751337	5243/1244/6514/142680/6519/340024/11136	7
WP3869	Cannabinoid receptor signaling	5/635	27/6030	0.148052755617607	0.479583894723193	0.389854620751337	1557/1559/1576/5600/6300	5
WP1434	Osteopontin signaling	3/635	13/6030	0.14993202505839	0.479583894723193	0.389854620751337	4318/5328/6696	3
WP5178	Disorders of fructose metabolism	3/635	13/6030	0.14993202505839	0.479583894723193	0.389854620751337	229/3795/6514	3
WP3645	NAD+ biosynthetic pathways	4/635	20/6030	0.152296262906729	0.483941414368093	0.393396856400346	952/3620/10135/6999	4
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	5/635	28/6030	0.165635231053376	0.522887690188107	0.425056354887576	9509/1277/1278/60681/4982	5
WP4564	Neural crest cell migration during development	6/635	36/6030	0.172228494139323	0.533476025453191	0.433663631892863	2047/2151/4313/4318/8503/7291	6
WP262	Ebstein-Barr virus LMP1 signaling	4/635	21/6030	0.173443929334429	0.533476025453191	0.433663631892863	6364/9260/7124/7185	4
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	4/635	21/6030	0.173443929334429	0.533476025453191	0.433663631892863	941/3101/3586/6515	4
WP3935	Leptin-insulin signaling overlap	3/635	14/6030	0.176720836589049	0.533476025453191	0.433663631892863	8503/8651/9021	3
WP4337	ncRNAs involved in STAT3 signaling in hepatocellular carcinoma	3/635	14/6030	0.176720836589049	0.533476025453191	0.433663631892863	3589/3569/652995	3
WP4582	Cancer immunotherapy by CTLA4 blockade	3/635	14/6030	0.176720836589049	0.533476025453191	0.433663631892863	941/1493/8503	3
WP5061	Fatty acid transporters	3/635	14/6030	0.176720836589049	0.533476025453191	0.433663631892863	2180/2182/2172	3
WP4331	Neovascularisation processes	6/635	37/6030	0.18856808338437	0.56570425015311	0.459862014399281	3091/4318/4854/4855/7042/7043	6
WP2203	Thymic stromal lymphopoietin (TSLP) signaling pathway	7/635	45/6030	0.189949408346093	0.566330643402239	0.460371210611387	6356/3055/3559/3569/3575/4067/6772	7
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	11/635	78/6030	0.193891837969544	0.574538391038587	0.467043303601162	467/22943/8061/11211/283120/5328/6423/6425/7480/7472/7474	11
WP3591	Sleep regulation	4/635	22/6030	0.195525391872211	0.575846123623647	0.468106361799325	100/134/3569/5730	4
WP4816	TGF-beta receptor signaling in skeletal dysplasias	8/635	54/6030	0.203440305954921	0.59201095456239	0.481246782285652	2022/2200/3458/3624/5054/6696/6772/7124	8
WP272	Blood clotting cascade	3/635	15/6030	0.204691158202731	0.59201095456239	0.481246782285652	5328/5054/7450	3
WP698	Glucuronidation	3/635	15/6030	0.204691158202731	0.59201095456239	0.481246782285652	54657/79799/7364	3
WP4357	NRF2-ARE regulation	4/635	23/6030	0.218408079249081	0.624207705782876	0.507419579943365	1051/2939/4094/23657	4
WP4585	Cancer immunotherapy by PD-1 blockade	4/635	23/6030	0.218408079249081	0.624207705782876	0.507419579943365	10538/29126/3458/80380	4
WP4241	Type 2 papillary renal cell carcinoma	5/635	31/6030	0.22274108222858	0.625950193015201	0.508836050985442	1513/112399/3091/7042/7043	5
WP4565	Neural crest cell migration in cancer	6/635	39/6030	0.222905658796303	0.625950193015201	0.508836050985442	2047/2151/4313/4318/8503/7291	6
WP534	Glycolysis and gluconeogenesis	6/635	39/6030	0.222905658796303	0.625950193015201	0.508836050985442	229/3099/3101/5313/6514/6515	6
WP3644	NAD+ metabolism	3/635	16/6030	0.233573613841798	0.648368134974645	0.527059636799701	952/10135/203447	3
WP4225	Pyrimidine metabolism and related diseases	3/635	16/6030	0.233573613841798	0.648368134974645	0.527059636799701	1373/5009/1890	3
WP3941	Oxidative damage response	6/635	40/6030	0.240797548038052	0.662740514646056	0.53874297038897	715/717/721/728/7124/7185	6
WP2324	AGE/RAGE pathway	9/635	65/6030	0.241495508442455	0.662740514646056	0.53874297038897	249/3091/3625/4322/4313/4316/4318/4843/6772	9
WP3298	Melatonin metabolism and effects	5/635	32/6030	0.242968467682657	0.663015649100131	0.538966627687368	1545/1557/1565/406938/4543	5
WP4830	GDNF/RET signaling axis	3/635	17/6030	0.263113330930392	0.713953588985277	0.580374171715175	2296/2674/26585	3
WP4900	Purinergic signaling	4/635	25/6030	0.266046416338299	0.717879436264796	0.583565500112823	134/5027/53829/5031	4
WP4172	PI3K-Akt signaling pathway	33/635	280/6030	0.268922551789798	0.721551585375161	0.586550596807094	285/1277/1278/1282/1284/1291/1293/84699/9586/1440/1441/2255/2252/2254/2786/3082/3559/3569/3575/3678/3918/10319/23566/5008/9180/5159/5228/8503/6696/7058/7097/3371/7450	33
WP560	TGF-beta receptor signaling	7/635	50/6030	0.270395107562949	0.721551585375161	0.586550596807094	2022/3458/3624/5054/6696/6772/7124	7
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	6/635	42/6030	0.277751665390673	0.735429322247208	0.597831834364626	330/6347/3569/4318/7124/7185	6
WP3863	T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection	8/635	59/6030	0.278640923335899	0.735429322247208	0.597831834364626	1437/1493/29851/3458/3586/3937/1326/7124	8
WP4846	SARS-CoV-2 and COVID-19 pathway	2/635	10/6030	0.284494091297913	0.746796989657021	0.607072631888566	59272/340024	2
WP3877	MYD88 distinct input-output pathway	3/635	18/6030	0.293072915165808	0.76515793527073	0.62199827799059	3552/7097/51311	3
WP2371	Parkinson's disease pathway	5/635	35/6030	0.306096414596958	0.794863270163068	0.646145798781354	120892/5600/6300/9627/9246	5
WP2197	Endothelin pathways	4/635	27/6030	0.315323120183249	0.797479255199656	0.64827233777808	1909/2769/4852/5739	4
WP3865	Novel intracellular components of RIG-I-like receptor (RLR) pathway	7/635	53/6030	0.322424889802814	0.797479255199656	0.64827233777808	843/3627/3458/9636/5600/6300/7124	7
WP5053	Development of ureteric collection system	7/635	53/6030	0.322424889802814	0.797479255199656	0.64827233777808	2296/158326/341640/2674/80000/6469/7042	7
WP4961	STING pathway in Kawasaki-like disease and COVID-19	3/635	19/6030	0.32323432294772	0.797479255199656	0.64827233777808	2212/3553/114548	3
WP5181	Roles of ceramides in the development of insulin resistance	3/635	19/6030	0.32323432294772	0.797479255199656	0.64827233777808	2180/7124/7185	3
WP229	Irinotecan pathway	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	1244/1576	2
WP3630	NAD metabolism, sirtuins and aging	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	3091/10135	2
WP3871	Valproic acid pathway	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	1555/1559	2
WP3930	EDA signaling in hair follicle development	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	22943/6469	2
WP4271	Vitamin B12 disorders	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	8029/6947	2
WP5052	Nephrogenesis	2/635	11/6030	0.325265865992406	0.797479255199656	0.64827233777808	8854/80000	2
WP2018	RANKL/RANK signaling pathway	7/635	54/6030	0.34014599803548	0.82588413127369	0.671362713228912	1513/3383/4067/6688/6772/4982/7185	7
WP2870	Extracellular vesicle-mediated signaling in recipient cells	4/635	28/6030	0.340271101704895	0.82588413127369	0.671362713228912	3082/7042/7043/7474	4
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	9/635	72/6030	0.345425886733956	0.829061932243377	0.673945953420027	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP4963	p53 transcriptional gene network	10/635	81/6030	0.346729835016899	0.829061932243377	0.673945953420027	6347/126129/55332/3383/9636/4688/5268/5054/23657/7124	10
WP5098	T-cell activation SARS-CoV-2	10/635	81/6030	0.346729835016899	0.829061932243377	0.673945953420027	941/1493/29851/3458/3594/3595/3605/51561/3937/7124	10
WP3640	Imatinib and chronic myeloid leukemia	3/635	20/6030	0.353399862954953	0.83264455515728	0.676858274106278	5243/5159/11040	3
WP4224	Purine metabolism and related disorders	3/635	20/6030	0.353399862954953	0.83264455515728	0.676858274106278	100/316/7498	3
WP4300	Extracellular vesicles in the crosstalk of cardiac cells	3/635	20/6030	0.353399862954953	0.83264455515728	0.676858274106278	3569/4318/6696	3
WP2814	Mammary gland development pathway - Puberty (Stage 2 of 4)	2/635	12/6030	0.365398189693186	0.844436964697651	0.686444345281081	8061/7076	2
WP2881	Estrogen receptor pathway	2/635	12/6030	0.365398189693186	0.844436964697651	0.686444345281081	1545/8431	2
WP4211	Transcriptional cascade regulating adipogenesis	2/635	12/6030	0.365398189693186	0.844436964697651	0.686444345281081	1051/1959	2
WP4792	Purine metabolism	2/635	12/6030	0.365398189693186	0.844436964697651	0.686444345281081	100/7498	2
WP306	Focal adhesion	21/635	183/6030	0.371502219403936	0.854455104629053	0.694588109461996	330/1277/1278/1282/1284/1290/50509/2268/2318/3055/3082/3678/3918/10319/5159/5228/8503/6696/7058/3371/7450	21
WP4018	Clear cell renal cell carcinoma pathways	10/635	83/6030	0.375997867994883	0.860696541429046	0.699661784794669	229/3091/3099/3101/4199/5159/5313/29968/7042/7043	10
WP4864	Host-pathogen interaction of human coronaviruses - apoptosis	3/635	21/6030	0.383392518558374	0.873483898413654	0.710056650557466	5600/6300/7124	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	4/635	30/6030	0.390232023599328	0.880757324291942	0.715969231689864	3624/6469/6615/7474	4
WP4868	Type I interferon induction and signaling during SARS-CoV-2 infection	4/635	30/6030	0.390232023599328	0.880757324291942	0.715969231689864	59272/4939/6772/7097	4
WP2828	Bladder cancer	5/635	39/6030	0.393049005538077	0.882989161278563	0.717783496037711	1839/4312/4313/4318/1890	5
WP2435	Quercetin and Nf-kB / AP-1 induced apoptosis	2/635	13/6030	0.404573855990422	0.888223511106244	0.72203850853793	4312/5743	2
WP2813	Mammary gland development pathway - Embryonic development (Stage 1 of 4)	2/635	13/6030	0.404573855990422	0.888223511106244	0.72203850853793	249/7124	2
WP5176	Disorders of bile acid synthesis and biliary transport	2/635	13/6030	0.404573855990422	0.888223511106244	0.72203850853793	1244/9420	2
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	2/635	13/6030	0.404573855990422	0.888223511106244	0.72203850853793	56624/3091	2
WP692	Sulfation biotransformation reaction	2/635	13/6030	0.404573855990422	0.888223511106244	0.72203850853793	6783/6822	2
WP357	Fatty acid biosynthesis	3/635	22/6030	0.413055749087768	0.898675345988252	0.730534824133416	2180/2182/6319	3
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	3/635	22/6030	0.413055749087768	0.898675345988252	0.730534824133416	1244/5600/6300	3
WP2406	Cardiac progenitor differentiation	4/635	31/6030	0.415045496394995	0.898955043761356	0.730762190962157	290/22943/3624/7070	4
WP69	T-cell receptor signaling pathway	10/635	86/6030	0.42025920398701	0.906183908596989	0.736638548341892	1234/29851/3601/3605/3552/3553/3569/3937/1326/3604	10
WP3925	Amino acid metabolism	9/635	77/6030	0.423337719346934	0.908764970864751	0.738736698556287	384/445/586/875/1373/3034/4942/5009/6999	9
WP5220	Metabolic reprogramming in pancreatic cancer	5/635	41/6030	0.436424351208977	0.925330478377421	0.752202829758697	3099/3949/4199/9122/8140	5
WP4666	Hepatitis B infection	15/635	134/6030	0.44190678327577	0.925330478377421	0.752202829758697	843/84699/9586/1959/1960/3569/5600/6300/4318/8503/6772/7042/7043/7097/7124	15
WP3845	Canonical and non-canonical Notch signaling	3/635	23/6030	0.442252899563571	0.925330478377421	0.752202829758697	4237/4854/4855	3
WP4483	Relationship between inflammation, COX-2 and EGFR	3/635	23/6030	0.442252899563571	0.925330478377421	0.752202829758697	4312/51365/5743	3
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	3/635	23/6030	0.442252899563571	0.925330478377421	0.752202829758697	3553/3569/10135	3
WP58	Monoamine GPCRs	2/635	14/6030	0.442549359223984	0.925330478377421	0.752202829758697	3274/3352	2
WP3945	TYROBP causal network in microglia	7/635	61/6030	0.465381404405162	0.960274002155737	0.780608483827155	10261/3687/3689/4094/4688/5341/6696	7
WP4746	Thyroid hormones production and peripheral downstream signaling effects	9/635	80/6030	0.470023542565802	0.960274002155737	0.780608483827155	1734/50506/405753/4852/5593/6469/5172/7038/7253	9
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	6/635	52/6030	0.47175434367125	0.960274002155737	0.780608483827155	602/79092/3575/9021/7124/7185	6
WP395	IL-4 signaling pathway	6/635	52/6030	0.47175434367125	0.960274002155737	0.780608483827155	1051/9046/5600/8651/9021/6772	6
WP5205	Clock-controlled autophagy in bone metabolism	8/635	71/6030	0.476154231837395	0.960274002155737	0.780608483827155	8553/115908/1513/22943/3569/4982/7480/7474	8
WP197	Cholesterol biosynthesis pathway	2/635	15/6030	0.479142928611869	0.960274002155737	0.780608483827155	4597/6713	2
WP2855	Dopaminergic neurogenesis	2/635	15/6030	0.479142928611869	0.960274002155737	0.780608483827155	4929/6469	2
WP4159	GABA receptor signaling	2/635	15/6030	0.479142928611869	0.960274002155737	0.780608483827155	2557/2562	2
WP4872	MAP3K1 role in promoting and blocking gonadal determination	2/635	15/6030	0.479142928611869	0.960274002155737	0.780608483827155	2254/5600	2
WP5182	Pro-survival signaling of neuroprotectin D1	2/635	15/6030	0.479142928611869	0.960274002155737	0.780608483827155	330/7124	2
WP4673	Male infertility	11/635	100/6030	0.487137602719958	0.969556828620466	0.788154510352912	5243/338/56603/2346/4313/4318/4843/29968/6648/7124/10537	11
WP1591	Heart development	4/635	34/6030	0.487789460361849	0.969556828620466	0.788154510352912	8553/2255/2296/6469	4
WP205	IL-7 signaling pathway	3/635	25/6030	0.498796312085734	0.975909941767798	0.793318967591563	3559/3575/6772	3
WP3613	Photodynamic therapy-induced unfolded protein response	3/635	25/6030	0.498796312085734	0.975909941767798	0.793318967591563	467/121506/6783	3
WP4950	16p11.2 distal deletion syndrome	3/635	25/6030	0.498796312085734	0.975909941767798	0.793318967591563	8519/5350/7185	3
WP2267	Synaptic vesicle pathway	5/635	44/6030	0.499993083215247	0.975909941767798	0.793318967591563	22999/246213/6507/6581/6532	5
WP2858	Ectoderm differentiation	13/635	120/6030	0.50108833448947	0.975909941767798	0.793318967591563	398/6347/1496/54898/57476/9687/152789/3801/3853/4061/6469/6781/4982	13
WP3594	Circadian rhythm genes	17/635	159/6030	0.512351932911777	0.981700858650859	0.798026414463922	100/134/56938/8553/1960/50865/3569/4543/4547/10135/4843/5551/5593/60675/5730/5054/6532	17
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	2/635	16/6030	0.514224259293307	0.981700858650859	0.798026414463922	3949/6319	2
WP368	Mitochondrial long chain fatty acid beta-oxidation	2/635	16/6030	0.514224259293307	0.981700858650859	0.798026414463922	2180/2182	2
WP4558	Overview of interferons-mediated signaling pathway	2/635	16/6030	0.514224259293307	0.981700858650859	0.798026414463922	3458/6772	2
WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	2/635	16/6030	0.514224259293307	0.981700858650859	0.798026414463922	3569/64386	2
WP4658	Small cell lung cancer	10/635	93/6030	0.522361540559728	0.992338358970882	0.806673657831838	330/1282/1284/3918/10319/4843/8503/5743/6258/7185	10
WP3851	TLR4 signaling and tolerance	3/635	26/6030	0.525959875562207	0.992338358970882	0.806673657831838	3569/11213/7124	3
WP4829	mBDNF and proBDNF regulation of GABA neurotransmission	3/635	26/6030	0.525959875562207	0.992338358970882	0.806673657831838	2557/2562/8503	3
WP254	Apoptosis	9/635	84/6030	0.53092923110653	0.997816414881144	0.811126779450075	330/834/843/3002/8739/3659/5551/7124/7185	9
WP3303	RAC1/PAK1/p38/MMP2 pathway	7/635	65/6030	0.534770743987487	0.999999644427312	0.812901530721124	285/9046/5600/6300/4313/4843/79931	7
WP100	Glutathione metabolism	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	290/2938	2
WP3678	Amplification and expansion of oncogenic pathways as metastatic traits	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	3371/7472	2
WP3874	Canonical and non-canonical TGF-B signaling	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	26585/4017	2
WP4784	Proteoglycan biosynthesis	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	9469/55790	2
WP4912	SARS coronavirus and innate immunity	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	59272/6772	2
WP5074	Kallmann syndrome	2/635	17/6030	0.547705716408363	0.999999644427312	0.812901530721124	60675/9723	2
WP2643	Nanoparticle-mediated activation of receptor signaling	3/635	27/6030	0.552289469984576	0.999999644427312	0.812901530721124	1277/5600/6300	3
WP286	IL-3 signaling pathway	5/635	47/6030	0.560619087812411	0.999999644427312	0.812901530721124	1232/1439/3055/3568/4067	5
WP399	Wnt signaling pathway and pluripotency	9/635	87/6030	0.57492903426256	0.999999644427312	0.812901530721124	8061/11211/3949/120892/4316/5328/7480/7472/7474	9
WP4150	Wnt signaling in kidney disease	3/635	28/6030	0.577731674178138	0.999999644427312	0.812901530721124	7480/7472/7474	3
WP4561	Cell migration and invasion through p75NTR	3/635	28/6030	0.577731674178138	0.999999644427312	0.812901530721124	4313/4318/7291	3
WP3859	TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition	2/635	18/6030	0.579534816563682	0.999999644427312	0.812901530721124	6615/3371	2
WP4760	PKC-gamma calcium signaling pathway in ataxia	2/635	18/6030	0.579534816563682	0.999999644427312	0.812901530721124	2769/2893	2
WP5193	Cholesterol synthesis disorders	2/635	18/6030	0.579534816563682	0.999999644427312	0.812901530721124	4597/6713	2
WP127	IL-5 signaling pathway	4/635	39/6030	0.599555340580559	0.999999644427312	0.812901530721124	1439/3568/4067/6772	4
WP408	Oxidative stress response	3/635	29/6030	0.602245873435719	0.999999644427312	0.812901530721124	3726/6648/7498	3
WP4698	Vitamin D-sensitive calcium signaling in depression	3/635	29/6030	0.602245873435719	0.999999644427312	0.812901530721124	775/1594/2906	3
WP1584	Type II diabetes mellitus	2/635	19/6030	0.609687815812619	0.999999644427312	0.812901530721124	6514/7124	2
WP325	Triacylglyceride synthesis	2/635	19/6030	0.609687815812619	0.999999644427312	0.812901530721124	56895/2819	2
WP4722	Glycerolipids and glycerophospholipids	2/635	19/6030	0.609687815812619	0.999999644427312	0.812901530721124	56895/80339	2
WP4657	22q11.2 copy number variation syndrome	9/635	90/6030	0.61701619797122	0.999999644427312	0.812901530721124	8854/9076/56603/2255/2296/4942/5625/6469/7450	9
WP4149	White fat cell differentiation	3/635	30/6030	0.625802967861984	0.999999644427312	0.812901530721124	1051/1959/7480	3
WP4313	Ferroptosis	6/635	61/6030	0.632612253164181	0.999999644427312	0.812901530721124	2180/2182/246/875/1803/23657	6
WP382	MAPK signaling pathway	21/635	210/6030	0.634846654148969	0.999999644427312	0.812901530721124	775/994/1846/2255/2252/2254/2318/3310/3552/3553/120892/1326/5600/6300/22808/5159/283748/115727/7042/7043/7124	21
WP2878	PPAR-alpha pathway	2/635	20/6030	0.638164255019026	0.999999644427312	0.812901530721124	335/345	2
WP3580	Methionine de novo and salvage pathway	2/635	20/6030	0.638164255019026	0.999999644427312	0.812901530721124	51074/259307	2
WP2332	Interleukin-11 signaling pathway	4/635	41/6030	0.639938874566544	0.999999644427312	0.812901530721124	3383/3589/9021/6772	4
WP4844	Influence of laminopathies on Wnt signaling	3/635	31/6030	0.648384125519161	0.999999644427312	0.812901530721124	1051/6696/7480	3
WP2359	Parkin-ubiquitin proteasomal system pathway	6/635	62/6030	0.648641728053008	0.999999644427312	0.812901530721124	834/3310/9627/10381/84617/9246	6
WP4823	Genes controlling nephrogenesis	3/635	32/6030	0.669979594117538	0.999999644427312	0.812901530721124	2296/5159/6469	3
WP1423	Ganglio sphingolipid metabolism	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	6482	1
WP2333	Trans-sulfuration pathway	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	875	1
WP2436	Dopamine metabolism	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	4129	1
WP3656	Interleukin-1 induced activation of NF-kB	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	3552	1
WP5050	TCA cycle in senescence	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	4199	1
WP5104	Acquired partial lipodystrophy / Barraquer-Simons syndrome	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	629	1
WP5187	mRNA vaccine activation of dendritic cell and induction of IFN-1	1/635	10/6030	0.671633024516919	0.999999644427312	0.812901530721124	51311	1
WP2586	Aryl hydrocarbon receptor pathway	4/635	43/6030	0.677569181962327	0.999999644427312	0.812901530721124	1545/135112/5743/7124	4
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	4/635	43/6030	0.677569181962327	0.999999644427312	0.812901530721124	775/2906/116443/8503	4
WP4482	Vitamin D in inflammatory diseases	2/635	22/6030	0.690174990886544	0.999999644427312	0.812901530721124	3569/7124	2
WP410	Exercise-induced circadian regulation	4/635	44/6030	0.695326791837035	0.999999644427312	0.812901530721124	1051/50486/2674/10381	4
WP3679	Cell-type dependent selectivity of CCK2R signaling	1/635	11/6030	0.70626974036937	0.999999644427312	0.812901530721124	952	1
WP4788	Autosomal recessive osteopetrosis pathways	1/635	11/6030	0.70626974036937	0.999999644427312	0.812901530721124	29887	1
WP4919	Neuroinflammation	1/635	11/6030	0.70626974036937	0.999999644427312	0.812901530721124	4843	1
WP4947	Nitric oxide metabolism in cystic fibrosis	1/635	11/6030	0.70626974036937	0.999999644427312	0.812901530721124	4843	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/635	11/6030	0.70626974036937	0.999999644427312	0.812901530721124	2358	1
WP170	Nuclear receptors	3/635	34/6030	0.710213205238591	0.999999644427312	0.812901530721124	9970/4929/6258	3
WP2361	Gastric cancer network 1	2/635	23/6030	0.713786618631589	0.999999644427312	0.812901530721124	11082/6286	2
WP34	Ovarian infertility	2/635	23/6030	0.713786618631589	0.999999644427312	0.812901530721124	1051/2701	2
WP5064	7-oxo-C and 7-beta-HC pathways	2/635	23/6030	0.713786618631589	0.999999644427312	0.812901530721124	134526/3290	2
WP428	Wnt signaling	9/635	98/6030	0.717672140523799	0.999999644427312	0.812901530721124	22943/8061/11211/5328/6423/6425/7480/7472/7474	9
WP3527	Pre-implantation embryo	3/635	35/6030	0.728867531573629	0.999999644427312	0.812901530721124	366/55509/94234	3
WP1539	Angiogenesis	2/635	24/6030	0.735870281725729	0.999999644427312	0.812901530721124	3091/4318	2
WP26	S1P receptor signal transduction	2/635	24/6030	0.735870281725729	0.999999644427312	0.812901530721124	6300/8877	2
WP2513	Nanoparticle triggered regulated necrosis	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	7124	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	22943	1
WP4190	Mevalonate arm of cholesterol biosynthesis pathway	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	4597	1
WP4504	Cysteine and methionine catabolism	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	875	1
WP5171	Leukotriene metabolic pathway	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	1800	1
WP5173	Disorders of galactose metabolism 	1/635	12/6030	0.737258063158114	0.999999644427312	0.812901530721124	6514	1
WP289	Myometrial relaxation and contraction pathways	12/635	131/6030	0.738752843435909	0.999999644427312	0.812901530721124	133/467/2786/3488/3553/3569/23764/5142/10268/6004/5999/8490	12
WP3931	Embryonic stem cell pluripotency pathways	8/635	91/6030	0.756395980058893	0.999999644427312	0.812901530721124	2255/2252/2254/6300/5159/7480/7472/7474	8
WP1528	Physiological and pathological hypertrophy of the heart	2/635	25/6030	0.756485409520511	0.999999644427312	0.812901530721124	183/5600	2
WP581	EPO receptor signaling	2/635	25/6030	0.756485409520511	0.999999644427312	0.812901530721124	8651/6772	2
WP304	Kit receptor signaling pathway	5/635	59/6030	0.759047129841082	0.999999644427312	0.812901530721124	3726/4067/6615/8651/6772	5
WP5037	Riboflavin and CoQ disorders	1/635	13/6030	0.764981747088755	0.999999644427312	0.812901530721124	55065	1
WP710	DNA damage response (only ATM dependent)	9/635	103/6030	0.770995274456906	0.999999644427312	0.812901530721124	8061/3949/5288/8503/5328/6648/7480/7472/7474	9
WP2272	Pathogenic Escherichia coli infection	4/635	49/6030	0.773549503079868	0.999999644427312	0.812901530721124	9076/23643/10381/84617	4
WP1422	Sphingolipid pathway	2/635	26/6030	0.775695870683703	0.999999644427312	0.812901530721124	56624/8877	2
WP241	One-carbon metabolism	2/635	26/6030	0.775695870683703	0.999999644427312	0.812901530721124	2346/2745	2
WP4875	Disruption of postsynaptic signaling by CNV	2/635	26/6030	0.775695870683703	0.999999644427312	0.812901530721124	2906/9378	2
WP4758	Nephrotic syndrome	3/635	38/6030	0.779184349965127	0.999999644427312	0.812901530721124	8542/1493/8029	3
WP3915	Angiopoietin-like protein 8 regulatory pathway	11/635	125/6030	0.779328567044062	0.999999644427312	0.812901530721124	64240/64241/1555/1576/1734/1326/5600/6300/5288/8503/6319	11
WP536	Calcium regulation in cardiac cells	11/635	125/6030	0.779328567044062	0.999999644427312	0.812901530721124	775/2701/2702/2709/10052/2786/3760/5350/6004/5999/8490	11
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/635	14/6030	0.789784238462968	0.999999644427312	0.812901530721124	283120	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/635	14/6030	0.789784238462968	0.999999644427312	0.812901530721124	1890	1
WP47	Hedgehog signaling pathway	1/635	14/6030	0.789784238462968	0.999999644427312	0.812901530721124	6469	1
WP2112	IL-17 signaling pathway	2/635	27/6030	0.793568382739633	0.999999644427312	0.812901530721124	1051/3605	2
WP2525	Trans-sulfuration and one-carbon metabolism	2/635	27/6030	0.793568382739633	0.999999644427312	0.812901530721124	875/29968	2
WP2533	Glycerophospholipid biosynthetic pathway	2/635	27/6030	0.793568382739633	0.999999644427312	0.812901530721124	2819/5320	2
WP5038	Mitochondrial immune response to SARS-CoV-2	2/635	27/6030	0.793568382739633	0.999999644427312	0.812901530721124	1636/59272	2
WP5085	Vasopressin-regulated water reabsorption	3/635	39/6030	0.794153434080508	0.999999644427312	0.812901530721124	398/84699/9586	3
WP1772	Apoptosis modulation and signaling	7/635	84/6030	0.795770276477977	0.999999644427312	0.812901530721124	597/330/664/834/843/8739/8794	7
WP4630	Measles virus infection	10/635	117/6030	0.801884861281241	0.999999644427312	0.812901530721124	3310/3552/3553/3559/3569/4939/8503/6504/6772/7097	10
WP3940	One-carbon metabolism and related pathways	3/635	40/6030	0.808267188266736	0.999999644427312	0.812901530721124	64902/586/6648	3
WP4222	Phosphodiesterases in neuronal function	3/635	40/6030	0.808267188266736	0.999999644427312	0.812901530721124	2906/10846/5142	3
WP4481	Resistin as a regulator of inflammation	2/635	28/6030	0.810171206475133	0.999999644427312	0.812901530721124	3569/7124	2
WP1946	Cori cycle	1/635	15/6030	0.811972903452332	0.999999644427312	0.812901530721124	6514	1
WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/635	15/6030	0.811972903452332	0.999999644427312	0.812901530721124	201294	1
WP4962	Airway smooth muscle cell contraction	1/635	15/6030	0.811972903452332	0.999999644427312	0.812901530721124	952	1
WP5101	Congenital generalized lipodystrophy (CGL)	1/635	15/6030	0.811972903452332	0.999999644427312	0.812901530721124	3091	1
WP314	Fas ligand pathway and stress induction of heat shock proteins	3/635	41/6030	0.82155626566412	0.999999644427312	0.812901530721124	843/3552/7124	3
WP4290	Metabolic reprogramming in colon cancer	3/635	41/6030	0.82155626566412	0.999999644427312	0.812901530721124	229/3101/29968	3
WP49	IL-2 signaling pathway	3/635	41/6030	0.82155626566412	0.999999644427312	0.812901530721124	3559/9021/6772	3
WP4321	Thermogenesis	8/635	98/6030	0.824330282231488	0.999999644427312	0.812901530721124	2180/2182/126129/84699/9586/5600/6300/5593	8
WP3972	PDGFR-beta pathway	2/635	29/6030	0.825573082996571	0.999999644427312	0.812901530721124	5159/6772	2
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/635	65/6030	0.829056680771085	0.999999644427312	0.812901530721124	941/9076/22943/4311/5329	5
WP22	IL-9 signaling pathway	1/635	16/6030	0.831822813062934	0.999999644427312	0.812901530721124	6772	1
WP4815	Glycosaminoglycan degradation	1/635	16/6030	0.831822813062934	0.999999644427312	0.812901530721124	3373	1
WP4970	Galanin receptor pathway	1/635	16/6030	0.831822813062934	0.999999644427312	0.812901530721124	3569	1
WP195	IL-1 signaling pathway	4/635	54/6030	0.835060321963345	0.999999644427312	0.812901530721124	6347/3552/3553/11213	4
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	5/635	66/6030	0.838950085184343	0.999999644427312	0.812901530721124	3638/3949/4597/6319/6713	5
WP143	Fatty acid beta-oxidation	2/635	30/6030	0.839842376934756	0.999999644427312	0.812901530721124	2180/2182	2
WP3858	Toll-like receptor signaling related to MyD88	2/635	30/6030	0.839842376934756	0.999999644427312	0.812901530721124	7097/51311	2
WP1971	Integrated cancer pathway	3/635	43/6030	0.84578881854441	0.999999644427312	0.812901530721124	994/4312/6772	3
WP5027	nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell	1/635	17/6030	0.849580131603845	0.999999644427312	0.812901530721124	728689	1
WP5200	Dravet syndrome	1/635	17/6030	0.849580131603845	0.999999644427312	0.812901530721124	5600	1
WP2636	Common pathways underlying drug addiction	2/635	31/6030	0.853046394273763	0.999999644427312	0.812901530721124	72/2893	2
WP4871	Kisspeptin/kisspeptin receptor system in the ovary	2/635	31/6030	0.853046394273763	0.999999644427312	0.812901530721124	3283/4318	2
WP2064	Neural crest differentiation	5/635	68/6030	0.857328165732465	0.999999644427312	0.812901530721124	4488/4854/4855/6615/7291	5
WP231	TNF-alpha signaling pathway	7/635	92/6030	0.865231786426986	0.999999644427312	0.812901530721124	330/6347/3569/1326/6401/7124/7185	7
WP3995	Prion disease pathway	2/635	32/6030	0.865250847617511	0.999999644427312	0.812901530721124	10538/6688	2
WP4542	Leukocyte-intrinsic Hippo pathway functions	2/635	32/6030	0.865250847617511	0.999999644427312	0.812901530721124	50943/639	2
WP3670	Interactions between LOXL4 and oxidative stress pathway	1/635	18/6030	0.865465150135619	0.999999644427312	0.812901530721124	2252	1
WP4301	Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells	1/635	18/6030	0.865465150135619	0.999999644427312	0.812901530721124	22808	1
WP4396	Nonalcoholic fatty liver disease	11/635	137/6030	0.86794421945465	0.999999644427312	0.812901530721124	6347/84701/3552/3553/3569/56901/9971/8503/5313/9021/7124	11
WP3529	Zinc homeostasis	2/635	33/6030	0.87651944548376	0.999999644427312	0.812901530721124	7780/169026	2
WP4874	CAMKK2 pathway	2/635	33/6030	0.87651944548376	0.999999644427312	0.812901530721124	3383/4094	2
WP4880	Host-pathogen interaction of human coronaviruses - interferon induction	2/635	33/6030	0.87651944548376	0.999999644427312	0.812901530721124	4939/6772	2
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/635	19/6030	0.879675002042452	0.999999644427312	0.812901530721124	8877	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/635	19/6030	0.879675002042452	0.999999644427312	0.812901530721124	3091	1
WP5103	Progeria-associated lipodystrophy	1/635	19/6030	0.879675002042452	0.999999644427312	0.812901530721124	2200	1
WP5194	Synthesis of ceramides and 1-deoxyceramides	1/635	19/6030	0.879675002042452	0.999999644427312	0.812901530721124	8877	1
WP4262	Breast cancer pathway	10/635	129/6030	0.885671611262727	0.999999644427312	0.812901530721124	2255/2252/2254/11211/4854/4855/8503/7480/7472/7474	10
WP400	p38 MAPK signaling pathway	2/635	34/6030	0.886913585499083	0.999999644427312	0.812901530721124	6772/7042	2
WP2507	Nanomaterial induced apoptosis	1/635	20/6030	0.892386093991054	0.999999644427312	0.812901530721124	5551	1
WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/635	20/6030	0.892386093991054	0.999999644427312	0.812901530721124	3002	1
WP4725	Sphingolipid metabolism overview	1/635	20/6030	0.892386093991054	0.999999644427312	0.812901530721124	8877	1
WP2637	Interleukin-1 (IL-1) structural pathway	3/635	49/6030	0.902102754188428	0.999999644427312	0.812901530721124	3552/1326/5600	3
WP4932	7q11.23 copy number variation syndrome	6/635	86/6030	0.902287418023626	0.999999644427312	0.812901530721124	9076/2200/3224/5313/9246/7472	6
WP4288	MTHFR deficiency	1/635	21/6030	0.903756282063546	0.999999644427312	0.812901530721124	2906	1
WP4726	Sphingolipid metabolism: integrated pathway	1/635	21/6030	0.903756282063546	0.999999644427312	0.812901530721124	8877	1
WP4905	1q21.1 copy number variation syndrome	1/635	21/6030	0.903756282063546	0.999999644427312	0.812901530721124	2702	1
WP2447	Amyotrophic lateral sclerosis (ALS)	2/635	36/6030	0.905311278797217	0.999999644427312	0.812901530721124	834/7124	2
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	2/635	36/6030	0.905311278797217	0.999999644427312	0.812901530721124	3488/8744	2
WP623	Oxidative phosphorylation	2/635	36/6030	0.905311278797217	0.999999644427312	0.812901530721124	3002/56901	2
WP2037	Prolactin signaling pathway	5/635	75/6030	0.908390354096948	0.999999644427312	0.812901530721124	3659/4843/8651/9021/6772	5
WP4148	Splicing factor NOVA regulated synaptic proteins	2/635	37/6030	0.913424437796548	0.999999644427312	0.812901530721124	1600/2898	2
WP4249	Hedgehog signaling pathway	2/635	37/6030	0.913424437796548	0.999999644427312	0.812901530721124	2619/6469	2
WP3872	Regulation of apoptosis by parathyroid hormone-related protein	1/635	22/6030	0.913926819738642	0.999999644427312	0.812901530721124	597	1
WP4537	Hippo-Yap signaling pathway	1/635	22/6030	0.913926819738642	0.999999644427312	0.812901530721124	3627	1
WP4686	Leucine, isoleucine and valine metabolism	1/635	22/6030	0.913926819738642	0.999999644427312	0.812901530721124	586	1
WP4217	Ebola virus infection in host	9/635	124/6030	0.917237281302676	0.999999644427312	0.812901530721124	432/684/93978/2318/3134/3678/8503/9021/6772	9
WP4541	Hippo-Merlin signaling dysregulation	7/635	101/6030	0.918934223420938	0.999999644427312	0.812901530721124	1001/1003/3627/3678/3687/3689/5159	7
WP500	Glycogen synthesis and degradation	2/635	38/6030	0.920882220453849	0.999999644427312	0.812901530721124	3099/3101	2
WP5124	Alzheimer's disease	18/635	226/6030	0.922441294658913	0.999999644427312	0.812901530721124	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP4906	3q29 copy number variation syndrome	3/635	52/6030	0.922640833225862	0.999999644427312	0.812901530721124	3091/8503/200931	3
WP3658	Wnt/beta-catenin signaling pathway in leukemia	1/635	23/6030	0.923024101607144	0.999999644427312	0.812901530721124	22943	1
WP3982	miRNA regulation of p53 pathway in prostate cancer	1/635	23/6030	0.923024101607144	0.999999644427312	0.812901530721124	5054	1
WP2355	Corticotropin-releasing hormone signaling pathway	5/635	78/6030	0.924858635869556	0.999999644427312	0.812901530721124	8061/3283/3726/4929/6822	5
WP2526	PDGF pathway	2/635	39/6030	0.927732425122678	0.999999644427312	0.812901530721124	5159/6772	2
WP585	Interferon type I signaling pathways	3/635	53/6030	0.928558988397625	0.999999644427312	0.812901530721124	8651/9021/6772	3
WP4521	Glycosylation and related congenital defects	1/635	24/6030	0.931161224210684	0.999999644427312	0.812901530721124	79644	1
WP4925	Unfolded protein response	1/635	24/6030	0.931161224210684	0.999999644427312	0.812901530721124	3553	1
WP4941	GPR143 in melanocytes and retinal pigment epithelium cells	1/635	24/6030	0.931161224210684	0.999999644427312	0.812901530721124	2769	1
WP2059	Alzheimer's disease and miRNA effects	18/635	229/6030	0.931558187422272	0.999999644427312	0.812901530721124	775/22943/11211/2906/3552/3553/3569/3800/4311/4843/8503/5743/7124/10381/84617/7480/7472/7474	18
WP4312	Rett syndrome causing genes	2/635	40/6030	0.934020069167728	0.999999644427312	0.812901530721124	3766/23221	2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	5/635	80/6030	0.934325758164378	0.999999644427312	0.812901530721124	183/8503/5320/7124/7474	5
WP268	Notch signaling	2/635	41/6030	0.939787443706375	0.999999644427312	0.812901530721124	4854/4855	2
WP4806	EGFR tyrosine kinase inhibitor resistance	5/635	82/6030	0.942712102587647	0.999999644427312	0.812901530721124	3082/3569/22808/5159/8503	5
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/635	26/6030	0.944949123655004	0.999999644427312	0.812901530721124	1051	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	2/635	42/6030	0.945074187650224	0.999999644427312	0.812901530721124	72/3689	2
WP4535	Envelope proteins and their potential roles in EDMD physiopathology	2/635	42/6030	0.945074187650224	0.999999644427312	0.812901530721124	7042/7043	2
WP61	Notch signaling pathway	3/635	57/6030	0.948301001704894	0.999999644427312	0.812901530721124	3091/4854/4855	3
WP4255	Non-small cell lung cancer	4/635	71/6030	0.950191233961768	0.999999644427312	0.812901530721124	1381/1382/8503/6258	4
WP3996	Ethanol effects on histone modifications	1/635	27/6030	0.950771459844057	0.999999644427312	0.812901530721124	8854	1
WP4856	Intracellular trafficking proteins involved in CMT neuropathy	1/635	27/6030	0.950771459844057	0.999999644427312	0.812901530721124	1959	1
WP5102	Familial partial lipodystrophy (FPLD)	1/635	27/6030	0.950771459844057	0.999999644427312	0.812901530721124	5396	1
WP5121	Sphingolipid metabolism in senescence	1/635	27/6030	0.950771459844057	0.999999644427312	0.812901530721124	8877	1
WP1403	AMP-activated protein kinase (AMPK) signaling	3/635	58/6030	0.952373979275901	0.999999644427312	0.812901530721124	126129/5209/8503	3
WP2038	Microtubule cytoskeleton regulation	2/635	44/6030	0.954351621208728	0.999999644427312	0.812901530721124	2151/11076	2
WP2583	T cell receptor and co-stimulatory signaling	1/635	28/6030	0.955978876635498	0.999999644427312	0.812901530721124	1493	1
WP183	Proteasome degradation	3/635	59/6030	0.956145994553423	0.999999644427312	0.812901530721124	3134/3458/5698	3
WP5072	Modulators of TCR signaling and T cell activation	3/635	59/6030	0.956145994553423	0.999999644427312	0.812901530721124	3937/1326/8651	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	3/635	60/6030	0.959637103875482	0.999999644427312	0.812901530721124	775/1496/3678	3
WP1601	Fluoropyrimidine activity	1/635	29/6030	0.960636226408317	0.999999644427312	0.812901530721124	1890	1
WP722	Serotonin HTR1 group and FOS pathway	1/635	29/6030	0.960636226408317	0.999999644427312	0.812901530721124	3352	1
WP4566	Translation inhibitors in chronically activated PDGFRA cells	2/635	46/6030	0.962120050229726	0.999999644427312	0.812901530721124	8503/11040	2
WP2034	Leptin signaling pathway	4/635	75/6030	0.963229064946702	0.999999644427312	0.812901530721124	3553/3557/9021/6772	4
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	1/635	30/6030	0.964801531562578	0.999999644427312	0.812901530721124	8503	1
WP3888	VEGFA-VEGFR2 signaling pathway	33/635	409/6030	0.964840106465808	0.999999644427312	0.812901530721124	56999/301/6347/1003/79094/1558/22943/1847/1960/2022/24147/6624/1839/3383/6300/4319/4313/4688/4855/4929/8013/5228/5328/5329/5743/27289/57758/6401/9047/6648/6772/8794/81567	33
WP5224	2q37 copy number variation syndrome	6/635	104/6030	0.969539229514945	0.999999644427312	0.812901530721124	1293/6373/27128/3553/7124/54657	6
WP3998	Prader-Willi and Angelman syndrome	1/635	32/6030	0.971858182005152	0.999999644427312	0.812901530721124	2562	1
WP244	Alpha 6 beta 4 signaling pathway	1/635	33/6030	0.974837517521446	0.999999644427312	0.812901530721124	3918	1
WP3981	miRNA regulation of prostate cancer signaling pathways	1/635	33/6030	0.974837517521446	0.999999644427312	0.812901530721124	5159	1
WP422	MAPK cascade	1/635	33/6030	0.974837517521446	0.999999644427312	0.812901530721124	6300	1
WP185	Integrin-mediated cell adhesion	5/635	94/6030	0.975682728031682	0.999999644427312	0.812901530721124	11131/3678/3687/3689/6300	5
WP3286	Copper homeostasis	2/635	51/6030	0.976381767143718	0.999999644427312	0.812901530721124	79689/54739	2
WP4659	Gastrin signaling pathway	6/635	108/6030	0.976919316989099	0.999999644427312	0.812901530721124	330/9076/4316/8503/5743/5054	6
WP313	Hepatocyte growth factor receptor signaling	1/635	34/6030	0.977501879097881	0.999999644427312	0.812901530721124	3082	1
WP4223	Ras signaling	10/635	161/6030	0.980137910489399	0.999999644427312	0.812901530721124	2786/22808/5159/8503/51365/84647/5320/50487/283748/115727	10
WP2795	Cardiac hypertrophic response	2/635	53/6030	0.9804911070927	0.999999644427312	0.812901530721124	5320/7124	2
WP4205	MET in type 1 papillary renal cell carcinoma	2/635	53/6030	0.9804911070927	0.999999644427312	0.812901530721124	3082/8503	2
WP4216	Chromosomal and microsatellite instability in colorectal cancer 	3/635	70/6030	0.982774195528388	0.999999644427312	0.812901530721124	5743/7042/7043	3
WP35	G protein signaling pathways	4/635	85/6030	0.983268843176416	0.999999644427312	0.812901530721124	2769/2786/3760/5142	4
WP524	G13 signaling pathway	1/635	37/6030	0.983920481117062	0.999999644427312	0.812901530721124	398	1
WP51	Regulation of actin cytoskeleton	7/635	127/6030	0.984672476291365	0.999999644427312	0.812901530721124	2255/2252/2254/22808/5159/5288/8503	7
WP3584	MECP2 and associated Rett syndrome	2/635	56/6030	0.985385179713802	0.999999644427312	0.812901530721124	2893/6890	2
WP4263	Pancreatic adenocarcinoma pathway	4/635	87/6030	0.985769812813655	0.999999644427312	0.812901530721124	8503/6772/7042/7043	4
WP366	TGF-beta signaling pathway	7/635	130/6030	0.987551153723929	0.999999644427312	0.812901530721124	467/1278/50943/3726/4312/4321/3371	7
WP2853	Endoderm differentiation	6/635	118/6030	0.988748669398315	0.999999644427312	0.812901530721124	22943/1846/1847/3227/6772/30009	6
WP4155	Endometrial cancer	2/635	61/6030	0.991015228047427	0.999999644427312	0.812901530721124	1496/8503	2
WP4971	Phosphoinositides metabolism	1/635	44/6030	0.992661596681158	0.999999644427312	0.812901530721124	5288	1
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	2/635	64/6030	0.993308399674182	0.999999644427312	0.812901530721124	6772/7253	2
WP4540	Hippo signaling regulation pathways	3/635	84/6030	0.995051629470856	0.999999644427312	0.812901530721124	1001/1003/5159	3
WP107	Translation factors	1/635	49/6030	0.995812000445075	0.999999644427312	0.812901530721124	728689	1
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	6/635	134/6030	0.996658734069247	0.999999644427312	0.812901530721124	249/1959/2562/4688/6696/6772	6
WP2857	Mesodermal commitment pathway	5/635	121/6030	0.997064275657666	0.999999644427312	0.812901530721124	8553/22943/2296/3624/6615	5
WP481	Insulin signaling	7/635	156/6030	0.998160359150517	0.999999644427312	0.812901530721124	1326/5600/6300/5288/8503/8651/9021	7
WP3680	Physico-chemical features and toxicity-associated pathways	1/635	58/6030	0.998475974668514	0.999999644427312	0.812901530721124	11211	1
WP4022	Pyrimidine metabolism	2/635	79/6030	0.998505893098196	0.999999644427312	0.812901530721124	956/1890	2
WP2261	Glioblastoma signaling pathways	2/635	82/6030	0.998897891382357	0.999999644427312	0.812901530721124	5159/5288	2
WP673	ErbB signaling pathway	2/635	83/6030	0.999004487025964	0.999999644427312	0.812901530721124	1839/8503	2
WP45	G1 to S cell cycle control	1/635	62/6030	0.999028036705911	0.999999644427312	0.812901530721124	84699	1
WP4685	Melanoma	1/635	63/6030	0.999131454382142	0.999999644427312	0.812901530721124	8503	1
WP437	EGF/EGFR signaling pathway	6/635	157/6030	0.999479203220092	0.999999644427312	0.812901530721124	9046/7837/9047/6456/6772/7291	6
WP4656	Joubert syndrome	1/635	71/6030	0.999647123659559	0.999999644427312	0.812901530721124	6469	1
WP179	Cell cycle	3/635	115/6030	0.999733709469052	0.999999644427312	0.812901530721124	994/7042/7043	3
WP23	B cell receptor signaling pathway	2/635	96/6030	0.999737820170338	0.999999644427312	0.812901530721124	27071/4067	2
WP138	Androgen receptor signaling pathway	1/635	85/6030	0.999927266328461	0.999999644427312	0.812901530721124	8431	1
WP2446	Retinoblastoma gene in cancer	1/635	86/6030	0.999935035189929	0.999999644427312	0.812901530721124	994	1
WP4549	Fragile X syndrome	1/635	101/6030	0.999988093945883	0.999999644427312	0.812901530721124	4318	1
WP4803	Ciliopathies	2/635	138/6030	0.999996861502326	0.999999644427312	0.812901530721124	122481/10309	2
WP411	mRNA processing	1/635	123/6030	0.999999019635065	0.999999644427312	0.812901530721124	10772	1
WP4352	Ciliary landscape	4/635	201/6030	0.999999644427312	0.999999644427312	0.812901530721124	875/3934/2040/339488	4
